Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Hypersensitivity | 13 | 2021 | 903 | 3.290 |
Why?
|
| Desensitization, Immunologic | 14 | 2020 | 546 | 2.380 |
Why?
|
| Skin Tests | 18 | 2020 | 630 | 2.310 |
Why?
|
| Anaphylaxis | 7 | 2020 | 738 | 1.500 |
Why?
|
| Urticaria | 4 | 2019 | 151 | 1.390 |
Why?
|
| Candidemia | 1 | 2020 | 40 | 0.680 |
Why?
|
| Tetracyclines | 1 | 2020 | 64 | 0.680 |
Why?
|
| Craniofacial Dysostosis | 1 | 2018 | 74 | 0.590 |
Why?
|
| Allergens | 4 | 2018 | 1436 | 0.580 |
Why?
|
| Anti-Bacterial Agents | 5 | 2020 | 7469 | 0.580 |
Why?
|
| Cold Temperature | 2 | 2018 | 793 | 0.570 |
Why?
|
| von Willebrand Disease, Type 3 | 1 | 2016 | 6 | 0.540 |
Why?
|
| Chromosomes, Human, X | 1 | 2018 | 319 | 0.540 |
Why?
|
| Pharmaceutical Preparations | 2 | 2021 | 1085 | 0.500 |
Why?
|
| Food Hypersensitivity | 3 | 2018 | 734 | 0.490 |
Why?
|
| Immunoglobulin E | 6 | 2016 | 1496 | 0.430 |
Why?
|
| von Willebrand Factor | 1 | 2016 | 680 | 0.400 |
Why?
|
| Antibody Specificity | 3 | 2012 | 1062 | 0.400 |
Why?
|
| Milk Hypersensitivity | 1 | 2012 | 83 | 0.380 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1559 | 0.370 |
Why?
|
| Intraoperative Complications | 1 | 2018 | 1171 | 0.370 |
Why?
|
| Cooking | 1 | 2012 | 327 | 0.340 |
Why?
|
| Methotrexate | 1 | 2016 | 1718 | 0.340 |
Why?
|
| Child | 20 | 2020 | 80771 | 0.250 |
Why?
|
| GATA2 Transcription Factor | 1 | 2015 | 158 | 0.240 |
Why?
|
| Antibodies, Monoclonal | 2 | 2017 | 9245 | 0.240 |
Why?
|
| Cross Reactions | 3 | 2018 | 828 | 0.230 |
Why?
|
| Pentobarbital | 1 | 2004 | 153 | 0.220 |
Why?
|
| Skin | 1 | 2017 | 4499 | 0.220 |
Why?
|
| Phenobarbital | 1 | 2004 | 192 | 0.220 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2013 | 168 | 0.190 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2015 | 549 | 0.190 |
Why?
|
| Immunotherapy | 1 | 2017 | 4745 | 0.190 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2015 | 329 | 0.190 |
Why?
|
| Drug Eruptions | 1 | 2004 | 335 | 0.180 |
Why?
|
| Echinocandins | 1 | 2020 | 54 | 0.170 |
Why?
|
| Clindamycin | 1 | 2018 | 138 | 0.150 |
Why?
|
| HLA-B Antigens | 1 | 2018 | 330 | 0.140 |
Why?
|
| Tryptases | 1 | 2018 | 175 | 0.140 |
Why?
|
| Adolescent | 11 | 2020 | 89046 | 0.140 |
Why?
|
| Food | 2 | 2018 | 766 | 0.130 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2018 | 231 | 0.130 |
Why?
|
| Hypnotics and Sedatives | 1 | 2004 | 1193 | 0.130 |
Why?
|
| Child, Preschool | 10 | 2019 | 42606 | 0.130 |
Why?
|
| Humans | 31 | 2021 | 767040 | 0.130 |
Why?
|
| Immunoconjugates | 1 | 2013 | 975 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 2020 | 760 | 0.120 |
Why?
|
| Benzyl Alcohol | 1 | 2004 | 6 | 0.120 |
Why?
|
| Penicillins | 1 | 2018 | 404 | 0.120 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2018 | 707 | 0.120 |
Why?
|
| Anticonvulsants | 1 | 2004 | 1921 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 733 | 0.110 |
Why?
|
| Observer Variation | 1 | 2018 | 2616 | 0.100 |
Why?
|
| Siblings | 1 | 2016 | 828 | 0.100 |
Why?
|
| Egg Hypersensitivity | 1 | 2012 | 47 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 15424 | 0.100 |
Why?
|
| Vitamin B 12 | 1 | 2004 | 529 | 0.090 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2004 | 348 | 0.090 |
Why?
|
| Eggs | 1 | 2012 | 182 | 0.090 |
Why?
|
| Nut Hypersensitivity | 1 | 2010 | 33 | 0.090 |
Why?
|
| Maternal Age | 1 | 2003 | 804 | 0.090 |
Why?
|
| Drug Tolerance | 1 | 2012 | 365 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2270 | 0.080 |
Why?
|
| Infant | 7 | 2018 | 36485 | 0.080 |
Why?
|
| Factor IX | 1 | 1998 | 76 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2018 | 1951 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2018 | 2647 | 0.070 |
Why?
|
| Medical History Taking | 1 | 2012 | 779 | 0.070 |
Why?
|
| Hemophilia B | 1 | 1998 | 83 | 0.070 |
Why?
|
| Peanut Hypersensitivity | 1 | 2010 | 217 | 0.070 |
Why?
|
| Female | 13 | 2020 | 396660 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2018 | 3076 | 0.070 |
Why?
|
| Delivery, Obstetric | 1 | 2003 | 949 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 5859 | 0.060 |
Why?
|
| Hot Temperature | 1 | 2012 | 1441 | 0.060 |
Why?
|
| Young Adult | 4 | 2020 | 59980 | 0.060 |
Why?
|
| Physical Examination | 1 | 2012 | 1265 | 0.060 |
Why?
|
| Male | 12 | 2020 | 364203 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2018 | 81659 | 0.060 |
Why?
|
| Drug Administration Routes | 1 | 2014 | 152 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14672 | 0.050 |
Why?
|
| Penicillin G | 1 | 2021 | 40 | 0.050 |
Why?
|
| Penicillanic Acid | 1 | 2021 | 41 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13650 | 0.040 |
Why?
|
| Adult | 6 | 2020 | 223317 | 0.040 |
Why?
|
| Immunization | 2 | 2016 | 1218 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 1998 | 1169 | 0.040 |
Why?
|
| Dideoxynucleosides | 1 | 2018 | 135 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2014 | 65295 | 0.040 |
Why?
|
| Carbamazepine | 1 | 2018 | 224 | 0.040 |
Why?
|
| Cefazolin | 1 | 2018 | 94 | 0.040 |
Why?
|
| Asthma | 1 | 2016 | 6268 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4855 | 0.030 |
Why?
|
| Pruritus | 1 | 2018 | 378 | 0.030 |
Why?
|
| Edema | 1 | 2018 | 764 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2018 | 619 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 15925 | 0.030 |
Why?
|
| Exanthema | 1 | 2018 | 502 | 0.030 |
Why?
|
| Infant Welfare | 1 | 2003 | 79 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2004 | 483 | 0.030 |
Why?
|
| Reference Standards | 1 | 2016 | 1011 | 0.030 |
Why?
|
| Risk | 2 | 2016 | 9606 | 0.020 |
Why?
|
| Patient Selection | 1 | 2014 | 4256 | 0.020 |
Why?
|
| Injections | 1 | 2004 | 839 | 0.020 |
Why?
|
| Cocos | 1 | 2010 | 8 | 0.020 |
Why?
|
| Sesamum | 1 | 2010 | 18 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 223233 | 0.020 |
Why?
|
| Child Welfare | 1 | 2003 | 522 | 0.020 |
Why?
|
| Radioallergosorbent Test | 1 | 1998 | 19 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2016 | 4026 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 171319 | 0.020 |
Why?
|
| Dermatitis, Atopic | 1 | 2003 | 734 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2004 | 1292 | 0.010 |
Why?
|
| ROC Curve | 1 | 2012 | 3618 | 0.010 |
Why?
|
| Risk Factors | 2 | 2014 | 74886 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13646 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2003 | 9660 | 0.010 |
Why?
|
| Boston | 1 | 2004 | 9360 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2016 | 3854 | 0.010 |
Why?
|
| Massachusetts | 1 | 2003 | 8890 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7435 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 13284 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 26396 | 0.010 |
Why?
|
| United States | 2 | 2016 | 72971 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 22254 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 168965 | 0.000 |
Why?
|
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(36)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_